Chesapeake Wealth Management’s Elevance Health ELV Stock Holding History

Chesapeake Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-772	Closed	-$379K	–	169
2022 Q1	$379K	Sell	772 -4	-0.5%	-$1.83K	0.14%	135
2021 Q4	$360K	Hold	776	–	–	0.12%	148
2021 Q3	$289K	Sell	776 -329	-30%	-$125K	0.1%	164
2021 Q2	$422K	Hold	1,105	–	–	0.14%	149
2021 Q1	$397K	Hold	1,105	–	–	0.13%	147
2020 Q4	$355K	Hold	1,105	–	–	0.12%	164
2020 Q3	$297K	Hold	1,105	–	–	0.11%	167
2020 Q2	$291K	Hold	1,105	–	–	0.12%	167
2020 Q1	$251K	Hold	1,105	–	–	0.12%	160
2019 Q4	$334K	Sell	1,105 -159	-13%	-$43.8K	0.13%	150
2019 Q3	$303K	Sell	1,264 -384	-23%	-$105K	0.12%	154
2019 Q2	$465K	Sell	1,648 -1,149	-41%	-$314K	0.19%	121
2019 Q1	$803K	Buy	2,797 +1,722	+160%	+$498K	0.35%	85
2018 Q4	$282K	Buy	1,075 +60	+6%	+$16.5K	0.14%	147
2018 Q3	$278K	Sell	1,015 -95	-9%	-$24.7K	0.12%	154
2018 Q2	$264K	Buy	+1,110	New	+$257K	0.12%	156

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Chesapeake Wealth Management's ELV Position: Q2 2022 in Review

Chesapeake Wealth Management sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 772 shares — an estimated $379K sold.

Chesapeake Wealth Management first reported a position in ELV in Q2 2018 and held it in 16 quarters. The position peaked at $803K in Q1 2019. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Chesapeake Wealth Management reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Chesapeake Wealth Management sold 772 Elevance Health shares in Q2 2022, an estimated $379K.
Chesapeake Wealth Management first reported a position in Elevance Health in Q2 2018 and held it in 16 quarters.
Chesapeake Wealth Management's Elevance Health position peaked at $803K in Q1 2019.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Chesapeake Wealth Management's 13F filing for Q2 2022, filed 21 Jul 2022.